# A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients

> **NCT00536666** · PHASE3 · COMPLETED · sponsor: **Pharmacosmos A/S** · enrollment: 182 (actual)

## Conditions studied

- Chronic Kidney Disease
- Anemia, Iron-Deficiency

## Interventions

- **DRUG:** Iron oligosaccharide

## Key facts

- **NCT ID:** NCT00536666
- **Lead sponsor:** Pharmacosmos A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2008-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00536666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00536666, "A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00536666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*